BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su FY, Zhao QH, Dahotre SN, Gamboa L, Bawage SS, Silva Trenkle AD, Zamat A, Phuengkham H, Ahmed R, Santangelo PJ, Kwong GA. In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles. Sci Adv 2022;8:eabm7950. [PMID: 35196075 DOI: 10.1126/sciadv.abm7950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang L, Gong L, Wang P, Zhao X, Zhao F, Zhang Z, Li Y, Huang W. Recent Advances in Lipid Nanoparticles for Delivery of mRNA. Pharmaceutics 2022;14:2682. [DOI: 10.3390/pharmaceutics14122682] [Reference Citation Analysis]
2 Huang X, Kong N, Zhang X, Cao Y, Langer R, Tao W. The landscape of mRNA nanomedicine. Nat Med 2022. [DOI: 10.1038/s41591-022-02061-1] [Reference Citation Analysis]
3 Mai D, June CH, Sheppard NC. In vivo gene immunotherapy for cancer. Sci Transl Med 2022;14. [DOI: 10.1126/scitranslmed.abo3603] [Reference Citation Analysis]
4 Patel SK, Billingsley MM, Frazee C, Han X, Swingle KL, Qin J, Alameh MG, Wang K, Weissman D, Mitchell MJ. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells. J Control Release 2022;347:521-32. [PMID: 35569584 DOI: 10.1016/j.jconrel.2022.05.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Metzloff AE, Billingsley MM, Mitchell MJ. Lighting the way to personalized mRNA immune cell therapies. Sci Adv 2022;8:eabo2423. [PMID: 35196095 DOI: 10.1126/sciadv.abo2423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]